Takeshi Fukumoto

ORCID: 0000-0003-0364-711X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Urticaria and Related Conditions
  • Global Health Care Issues
  • Global Maternal and Child Health
  • Climate Change and Health Impacts
  • Chromatin Remodeling and Cancer
  • Cancer Mechanisms and Therapy
  • Health disparities and outcomes
  • Dermatology and Skin Diseases
  • Autoimmune Bullous Skin Diseases
  • Dermatologic Treatments and Research
  • Cutaneous Melanoma Detection and Management
  • Child Nutrition and Water Access
  • melanin and skin pigmentation
  • Global Public Health Policies and Epidemiology
  • Healthcare Systems and Reforms
  • Contact Dermatitis and Allergies
  • Mast cells and histamine
  • Nail Diseases and Treatments
  • Cutaneous lymphoproliferative disorders research
  • Skin Diseases and Diabetes
  • Cancer Immunotherapy and Biomarkers
  • Nonmelanoma Skin Cancer Studies
  • Trauma and Emergency Care Studies
  • Injury Epidemiology and Prevention
  • Melanoma and MAPK Pathways

Kobe University
2016-2025

Kobe City Nishi-Kobe Medical Center
2025

Institute for Health Metrics and Evaluation
2018-2023

Royal North Shore Hospital
2023

The University of Sydney
2023

University of Electronic Science and Technology of China
2023

University of Washington
2018-2022

University of California, Davis
2021

The Wistar Institute
2017-2021

University College London
2021

Joseph R. Zunt Nicholas J Kassebaum Natacha Blake Linda Glennie Claire Wright and 95 more Emma Nichols Foad Abd-Allah Jemal Abdela Ahmed Abdelalim Abdu A. Adamu Mina G Adib Alireza Ahmadi Muktar Beshir Ahmed Amani Nidhal Aichour Ibtihel Aichour Miloud Taki Eddine Aichour Nadia Akseer Rajaa Al‐Raddadi Fares Alahdab Kefyalew Addis Alene Syed Mohamed Aljunid Mohammad A. AlMazroa Khalid A Altirkawi Nelson Alvis‐Guzmán Megbaru Debalkie Animut Mina Anjomshoa Mustafa Geleto Ansha Rana Jawad Asghar Euripide Frinel G Arthur Avokpaho Ashish Awasthi Hamid Badali Aleksandra Barać Till Bärnighausen Quique Bassat Neeraj Bedi Abate Bekele Belachew Krittika Bhattacharyya Zulfiqar A Bhutta Ali Bijani Zahid A Butt Félix Carvalho Carlos A Castañeda-Orjuela Abdulaal Chitheer Jee-Young J Choi Devasahayam Jesudas Christopher Anh Kim Dang Ahmad Daryani Gebre Teklemariam Demoz Shirin Djalalinia Huyen Phuc Manisha Dubey Eleonora Dubljanin Eyasu Ejeta Duken Maysaa El Sayed Zaki Iqbal Elyazar Hamed Fakhim Eduarda Fernandes Florian Fischer Takeshi Fukumoto Morsaleh Ganji Abadi Kahsu Gebre Afewerki Gebremeskel Bradford D. Gessner Sameer Vali Gopalani Yuming Guo Rahul Gupta Gessessew Bugssa Hailu Arvin Haj‐Mirzaian Samer Hamidi Simon I Hay Andualem Henok Seyed Sina Naghibi Irvani Ravi Prakash Jha Mikk Jürisson Amaha Kahsay Manoochehr Karami André Karch Amir Kasaeian Getachew Mullu Kassa Tesfaye Kassa Adane Teshome Kefale Yousef Khader Fakher Rahim Ejaz Ahmad Khan Young‐Ho Khang Jagdish Khubchandani Ruth W Kimokoti Adnan Kısa Pawan Faris Miriam Levi Shanshan Li Clement T. Loy Marek Majdán Azeem Majeed LG Mantovani Francisco Rogerlândio Martins‐Melo Colm McAlinden Varshil Mehta Addisu Melese Ziad A. Memish

Acute meningitis has a high case-fatality rate and survivors can have severe lifelong disability. We aimed to provide comprehensive assessment of the levels trends global burden that could help guide introduction, continuation, ongoing development vaccines treatment programmes.

10.1016/s1474-4422(18)30387-9 article EN cc-by The Lancet Neurology 2018-11-13
Lisa M Force Ibrahim Abdollahpour Shailesh M Advani Dominic Agius Elham Ahmadian and 95 more Fares Alahdab Shazia Alam Animut Alebel Vahid Alipour Christine A. Allen Amir Almasi‐Hashiani Elysia Alvarez Saeed Amini Yaw Ampem Amoako Nahla Anber Jalal Arabloo Al Artaman Suleman Atique Ashish Awasthi Mojtaba Bagherzadeh Huda Basaleem Eyasu Tamru Bekru Ali Bijani Kassawmar Angaw Bogale Mate Car Félix Carvalho Clara Castro Ferrán Catalá-López Dinh‐Toi Chu Vera Marisa Costa Amira Hamed Darwish Feleke Mekonnen Demeke Asmamaw Demis Gebre Teklemariam Demoz Samath D Dharmaratne Huyen Phuc Linh Phuong Doan Manisha Dubey Aziz Eftekhari Ziad El‐Khatib Mohammad Hassan Emamian Mahdieh Abbasalizad Farhangi Eduarda Fernandes Florian Fischer Reza Fouladi Fard Paola Friedrich Takeshi Fukumoto Getnet Gedefaw Ahmad Ghashghaee Asadollah Gholamian Arvin Haj‐Mirzaian Arya Haj‐Mirzaian Samer Hamidi James Harvey Hamid Yimam Hassen Simon I Hay Chi Linh Hoang Michael K. Hole Nobuyuki Horita Seyyed Nasrollah Hosseini Mehdi Hosseinzadeh Mohamed Hsaïri Melissa Maria Hudson Kaire Innos Farzad Jalilian Spencer L James Amir Kasaeian Tesfaye Kassa Nicholas J Kassebaum Peter Njenga Keiyoro Yousef Khader Jagdish Khubchandani Neda Kianipour Jeannette Kirby Adnan Kısa Sezer Kısa Jonathan Kocarnik Paolo Lauriola Alan D Lopez Margit Mägi Manzoor Ahmad Malik Ali Manafi Navid Manafi Mohammad Alì Mansournia Benjamin B. Massenburg Varshil Mehta Hagazi Gebre Meles Tuomo J Meretoja Tomislav Meštrović Seyed Mostafa Mir Mehdi Mirzaei-Alavijeh Mohammad H Forouzanfar Aso Mohammad Darwesh Naser Mohammad Gholi Mezerji Roghayeh Mohammadibakhsh Milad Mohammadoo-Khorasani Ali H. Mokdad Yoshan Moodley Mahmood Moosazadeh Maryam Moossavi

<h2>Summary</h2><h3>Background</h3> Accurate childhood cancer burden data are crucial for resource planning and health policy prioritisation. Model-based estimates necessary because surveillance scarce or non-existent in many countries. Although global incidence mortality available, there no previous analyses of the represented disability-adjusted life-years (DALYs). <h3>Methods</h3> Using Global Burden Diseases, Injuries, Risk Factors Study (GBD) 2017 methodology, (ages 0–19 years) was...

10.1016/s1470-2045(19)30339-0 article EN cc-by The Lancet Oncology 2019-07-29
Annie Haakenstad Caleb Mackay Salpeter Irvine Megan Knight Corinne Bintz Aleksandr Y. Aravkin and 95 more Peng Zheng Vin Gupta Michael R.M. Abrigo Abdelrahman Ibrahim Abushouk Oladimeji Adebayo Gina Agarwal Fares Alahdab Ziyad Al‐Aly Khurshid Alam Turki Alanzi Jacqueline Elizabeth Alcalde‐Rabanal Vahid Alipour Nelson Alvis‐Guzmán Arianna Maever L. Amit Cătălina Liliana Andrei Tudorel Andrei Carl Abelardo T Antonio Jalal Arabloo Olatunde Aremu Martin Amogre Ayanore Maciej Banach Till Bärnighausen Celine M Barthelemy Mohsen Bayati Habib Benzian Adam E. Berman Kelly Bienhoff Ali Bijani Boris Bikbov Antonio Biondi Archith Boloor Reinhard Busse Zahid A Butt Luis Alberto Cámera Ismael Campos‐Nonato Rosario Cárdenas Félix Carvalho Collins Chansa Soosanna Kumary Chattu Vijay Kumar Chattu Dinh‐Toi Chu Xiaochen Dai Lalit Dandona Rakhi Dandona William James Dangel Ahmad Daryani Jan‐Walter De Neve Meghnath Dhimal Isaac Oluwafemi Dipeolu Shirin Djalalinia Hoa Do Chirag Doshi Leila Doshmangir Elham Ehsani‐Chimeh Maha El Tantawi Eduarda Fernandes Florian Fischer Nataliya A Foigt Artem Alekseevich Fomenkov Masoud Foroutan Takeshi Fukumoto Nancy Fullman Mohamed Gad Keyghobad Ghadiri Mansour Ghafourifard Ahmad Ghashghaee Thomas Glucksman Houman Goudarzi Rajat Das Gupta Randah R Hamadeh Samer Hamidi Josep María Haro Edris Hasanpoor Simon I Hay Mohamed Hegazy Behzad Heibati Nathaniel J Henry Michael K. Hole Naznin Hossain Mowafa Househ Olayinka Stephen Ilesanmi Mohammad Hasan Imani-Nasab Seyed Sina Naghibi Irvani Sheikh Mohammed Shariful Islam Mohammad Ali Jahani Ankur Joshi Rohollah Kalhor Gbenga A Kayode Nauman Khalid Khaled Khatab Adnan Kısa Sonali Kochhar Kewal Krishan Barthélémy Kuate Defo G Anil Kumar

Human resources for health (HRH) include a range of occupations that aim to promote or improve human health. The UN Sustainable Development Goals (SDGs) and the WHO Health Workforce 2030 strategy have drawn attention importance HRH achieving policy priorities such as universal coverage (UHC). Although previous research has found substantial global disparities in HRH, absence comparable cross-national estimates existing workforces hindered efforts quantify workforce requirements meet system...

10.1016/s0140-6736(22)00532-3 article EN cc-by The Lancet 2022-05-23
Rachel Black Marita Cross Teklehaimanot Gereziher Haile Garland T Culbreth Jaimie D Steinmetz and 95 more Hailey Hagins Jacek A Kopec Peter Brooks Anthony D. Woolf Kanyin Liane Ong Deborah Kopansky-Giles Karsten E Dreinhoefer Neil Betteridge Amirali Aali Mitra Abbasifard Mohsen Abbasi‐Kangevari Ame Mehadi Aidin Abedi Hassan Abidi Richard Gyan Aboagye Hassan Abolhassani Eman Abu‐Gharbieh Ahmed Abu‐Zaid Kidist Adamu Isaac Yeboah Addo Miracle Ayomikun Adesina Qorinah Estiningtyas Sakilah Adnani Muhammad U. Afzal Ayman Ahmed Janardhana P Aithala Meisam Akhlaghdoust Astawus Alemayehu Saba Alvand Nelson J. Alvis-Zakzuk Hubert Amu Benny Antony Jalal Arabloo Aleksandr Y. Aravkin Judie Arulappan Tahira Ashraf Seyyed Shamsadin Athari Sina Azadnajafabad Alaa Badawi Nayereh Baghcheghi Atif Amin Baig Asaminew Birhanu Balta Maciej Banach Palash Chandra Banik Amadou Barrow Azadeh Bashiri Lindsay Bearne Alehegn Bekele Isabela M. Benseñor Alemshet Yirga Berhie Akshaya Srikanth Bhagavathula Pankaj Bhardwaj Ajay Nagesh Bhat Vijayalakshmi S Bhojaraja Saeid Bitaraf Belay Boda Abule Bodicha João Botelho Andrew M. Briggs Rachelle Buchbinder Carlos A Castañeda-Orjuela Periklis Charalampous Vijay Kumar Chattu Kaleb Coberly Natália Martins Omid Dadras Xiaochen Dai Katie de Luca Fikadu Nugusu Dessalegn Gashaw Dessie Meghnath Dhimal Lankamo Ena Digesa Mengistie Diress Paul Narh Doku Hisham Atan Edinur Michael Ekholuenetale Muhammed Elhadi Yasser M. El‐Sherbiny Farshid Etaee Rana Ezzeddini Shahriar Faghani Irina Filip Florian Fischer Takeshi Fukumoto Balasankar Ganesan Mathewos Alemu Gebremichael Urge Gerema Motuma Erena Getachew Ahmad Ghashghaee Tiffany K. Gill Bhawna Gupta Sapna Gupta Veer Bala Gupta Vivek Gupta Rabih Halwani Md. Abdul Hannan Shafiul Haque

10.1016/s2665-9913(23)00211-4 article EN The Lancet Rheumatology 2023-09-25
Rajesh Sharma Hedayat Abbastabar Deldar Morad Abdulah Hassan Abidi Hassan Abolhassani and 95 more Zahra Abrehdari-Tafreshi Abdorrahim Absalan Hiwa Abubaker Ali Eman Abu‐Gharbieh Juan Acuña Nasrin Adib Qorinah Estiningtyas Sakilah Adnani Abbas Aghaei Aqeel Ahmad Sajjad Ahmad Ali Ahmadi Sepideh Ahmadi Luai A. Ahmed Marjan Ajami Hanadi Al Hamad Syed Mahfuz Al Hasan Fahad Mashhour Alanezi Adel Al‐Gheethi Mohammed Khaled Al‐Hanawi Abid Ali Beriwan Abdulqadir Ali Yousef Alimohamadi Syed Mohamed Aljunid Sadeq Ali Al‐Maweri Saleh A Alqahatni Mohammad A. Y. Alqudah Rajaa Al‐Raddadi Ala’a B. Al‐Tammemi Alireza Ansari-Moghaddam KM Shivakumar Razique Anwer Muhammad Aqeel Jalal Arabloo Morteza Arab‐Zozani Hany Ariffin Al Artaman Judie Arulappan Tahira Ashraf Elaheh Askari Mohammad Athar Maha Atout Sina Azadnajafabad Muhammad Badar Ashish Badiye Nayereh Baghcheghi Sara Bagherieh Ruhai Bai Khuloud Bajbouj Shrikala Baliga Mainak Bardhan Azadeh Bashiri Pritish Baskaran Saurav Basu Uzma Belgaumi Amiel Nazer C. Bermudez Bharti Bhandari Nikha Bhardwaj Ajay Nagesh Bhat Saeid Bitaraf Archith Boloor Milad Bonakdar Hashemi Zahid A Butt Joshua Chadwick Jeffrey Shi Kai Chan Vijay Kumar Chattu Pankaj Chaturvedi William C. Cho Aso Mohammad Darwesh Nihar Ranjan Dash Amin Dehghan Arkadeep Dhali Mostafa Dianatinasab Mahmoud Dibas Abhinav Dixit Shilpi Gupta Dixit Fariba Dorostkar Haneil Larson Dsouza Iffat Elbarazi Noha Mousaad Elemam Waseem El‐Huneidi Eyad Elkord Omar El Meligy Mohammad Hassan Emamian Ryenchindorj Erkhembayar Rana Ezzeddini Zehra Fadoo Razana Faiz Ildar Fakhradiyev Aida Fallahzadeh MoezAlIslam E. Faris Hossein Farrokhpour Ali Fatehizadeh Hamed Fattahi Ginenus Fekadu Takeshi Fukumoto

Cancers represent a challenging public health threat in Asia. This study examines the temporal patterns of incidence, mortality, disability and risk factors 29 cancers Asia last three decades. The age, sex year-wise estimates disability-adjusted life years (DALYs) for 49 Asian countries from 1990 through 2019 were generated as part Global Burden Disease, Injuries Risk Factors study. Besides mortality DALYs, we also examined cancer burden measured terms DALYs deaths attributable to factors,...

10.1016/j.lansea.2023.100333 article EN cc-by The Lancet Regional Health - Southeast Asia 2024-01-02

Abstract Despite the high initial response rates to PARP inhibitors (PARPi) in BRCA-mutated epithelial ovarian cancers (EOC), PARPi resistance remains a major challenge. Chemical modifications of RNAs have emerged as new layer epigenetic gene regulation. N6-methyladenosine (m6A) is most abundant chemical modification mRNA, yet role m6A has not previously been explored. Here, we show that FZD10 mRNA contributes by upregulating Wnt/β-catenin pathway EOC cells. Global profile revealed...

10.1158/0008-5472.can-18-3592 article EN Cancer Research 2019-04-09

Epithelial ovarian cancer (EOC) is the most lethal of gynecologic malignancies. The standard-of-care treatment for EOC platinum-based chemotherapy such as cisplatin. Platinum-based induces cellular senescence. Notably, therapy-induced senescence contributes to chemoresistance by inducing stem-like cells (CSC). However, therapeutic approaches targeting senescence-associated CSCs remain be explored. Here, we show that nicotinamide phosphoribosyltransferase (NAMPT) inhibition suppresses induced...

10.1158/0008-5472.can-19-2830 article EN Cancer Research 2019-12-19

ARID1A, a subunit of the SWI/SNF complex, is among most frequently mutated genes across cancer types. ARID1A in more than 50% ovarian clear cell carcinomas (OCCCs), diseases that have no effective therapy. Here, we show mutation confers sensitivity to pan-HDAC inhibitors such as SAHA cancers. This correlated with enhanced growth suppression induced by inhibition HDAC2 activity ARID1A-mutated cells. interacts EZH2 an status-dependent manner. functions co-repressor suppress expression...

10.1016/j.celrep.2018.03.019 article EN cc-by-nc-nd Cell Reports 2018-03-01

Background As global rates of mortality decrease, non-fatal injury have increased, particularly in low Socio-demographic Index (SDI) nations. We hypothesised this pattern would be demonstrated regard to bony hand and wrist trauma over the 27-year study period. Methods The Global Burden Diseases, Injuries, Risk Factors Study 2017 was used estimate prevalence, age-standardised incidence years lived with disability for 195 countries from 1990 2017. Individual injuries included fractures, thumb...

10.1136/injuryprev-2019-043495 article EN cc-by Injury Prevention 2020-03-13
Juanita A. Haagsma Spencer L James Chris D Castle Zachary V Dingels Jack T Fox and 95 more Erin B Hamilton Zichen Liu Lydia R Lucchesi Nicholas L S Roberts Dillon O Sylte Oladimeji Adebayo Alireza Ahmadi Muktar Beshir Ahmed Miloud Taki Eddine Aichour Fares Alahdab Suliman Alghnam Syed Mohamed Aljunid Rajaa Al‐Raddadi Ubai Alsharif Khalid A Altirkawi Mina Anjomshoa Carl Abelardo T. Antonio Seth Christopher Yaw Appiah Olatunde Aremu Amit Arora Hamid Asayesh Reza Assadi Ashish Awasthi Beatriz Paulina Ayala Quintanilla Shivanthi Balalla Amrit Banstola Suzanne Barker‐Collo Till Bärnighausen Shahrzad Bazargan‐Hejazi Neeraj Bedi Masoud Behzadifar Masoud Behzadifar Corina Benjet Derrick Bennett Isabela M. Benseñor Soumyadeep Bhaumik Zulfiqar A Bhutta Ali Bijani Guilherme Borges Rohan Borschmann Dipan Bose Soufiane Boufous Alexandra Bražinová Julio César Campuzano Rosario Cárdenas Juan Jesús Carrero Félix Carvalho Carlos A Castañeda-Orjuela Ferrán Catalá-López Jee-Young Jasmine Choi Devasahayam Jesudas Christopher Christopher S. Crowe Koustuv Dalal Ahmad Daryani Dragoş Virgil Daviţoiu Louisa Degenhardt Diego De Leo Jan‐Walter De Neve Kebede Deribe Getenet Dessie Gabrielle deVeber Samath D Dharmaratne Linh Phuong Doan Kate Dolan Tim Driscoll Manisha Dubey Ziad El‐Khatib Christian Lycke Ellingsen Maysaa El Sayed Zaki Aman Yesuf Endries Sharareh Eskandarieh André Faro Seyed‐Mohammad Fereshtehnejad Eduarda Fernandes Irina Filip Florian Fischer Richard C. Franklin Takeshi Fukumoto Kebede Embaye Gezae Tiffany K Gill Alessandra C. Goulart Ayman Grada Yuming Guo Rahul Gupta Hassan Haghparast‐Bidgoli Arvin Haj‐Mirzaian Arya Haj‐Mirzaian Randah R Hamadeh Samer Hamidi Josep María Haro Hadi Hassankhani Hamid Yimam Hassen Rasmus Havmoeller Delia Hendrie Andualem Henok

The epidemiological transition of non-communicable diseases replacing infectious as the main contributors to disease burden has been well documented in global health literature. Less focus, however, given relationship between sociodemographic changes and injury. aim this study was examine association disability-adjusted life years (DALYs) from injury for 195 countries territories at different levels along development spectrum 1990 2017 based on Global Burden Disease (GBD) estimates.Injury...

10.1136/injuryprev-2019-043296 article EN cc-by Injury Prevention 2020-01-08

Therapy-induced senescence-associated secretory phenotype (SASP) correlates with overcoming resistance to immune checkpoint blockade (ICB). Intrinsic ICB is a major clinical challenge. For example, ovarian cancer largely resistant ICB. Here we show that adoptive transfer of SASP-boosted ex vivo therapy-induced senescent cells sensitizes tumor Topoisomerase 1 (TOP1) inhibitors such as irinotecan enhance cisplatin-induced SASP, which depends on the TOP1 cleavage complex-regulated cGAS pathway....

10.1016/j.isci.2020.102016 article EN cc-by-nc-nd iScience 2020-12-30

<h3>Importance</h3> Skin and subcutaneous diseases affect the health of millions individuals in US. Data are needed that highlight geographic trends variations skin disease burden across country to guide care decision-making. <h3>Objective</h3> To characterize tissue US from 1990 2017. <h3>Design, Setting, Participants</h3> For this cohort study, data were obtained Global Burden Disease (GBD), a study with an online database incorporates current previous epidemiological studies burden, GBD...

10.1001/jamadermatol.2020.1573 article EN JAMA Dermatology 2020-06-10

Abstract Cyclic cGMP-AMP synthase (cGAS) is a pattern recognition cytosolic DNA sensor that essential for cellular senescence. cGAS promotes inflammatory senescence-associated secretory phenotype (SASP) through recognizing cytoplasmic chromatin during cGAS-mediated inflammation the antitumor effects of immune checkpoint blockade. However, mechanism by which recognizes unknown. Here we show topoisomerase 1-DNA covalent cleavage complex (TOP1cc) both necessary and sufficient SASP TOP1cc...

10.1038/s41467-020-14652-y article EN cc-by Nature Communications 2020-02-19
Emily Haeuser Audrey L. Serfes Michael A. Cork Mingyou Yang Hedayat Abbastabar and 95 more E S Abhilash Maryam Adabi Oladimeji Adebayo Victor Adekanmbi Daniel Adedayo Adeyinka Saira Afzal Bright Opoku Ahinkorah Keivan Ahmadi Muktar Beshir Ahmed Yonas Akalu Rufus Akinyemi Chisom Joyqueenet Akunna Fares Alahdab Fahad Mashhour Alanezi Turki Alanzi Kefyalew Addis Alene Robert Kaba Alhassan Vahid Alipour Amir Almasi‐Hashiani Nelson Alvis‐Guzmán Edward Kwabena Ameyaw GK Mini Dickson A Amugsi Robert Ancuceanu Davood Anvari Seth Christopher Yaw Appiah Jalal Arabloo Olatunde Aremu Mulusew Andualem Asemahagn Mohammad Asghari Jafarabadi Atalel Fentahun Awedew Beatriz Paulina Ayala Quintanilla Martin Amogre Ayanore Yared Asmare Aynalem Samad Azari Zelalem Nigussie Azene B B Darshan Tesleem Kayode Babalola Atif Amin Baig Maciej Banach Till Bärnighausen Arielle Wilder Bell Akshaya Srikanth Bhagavathula Nikha Bhardwaj Pankaj Bhardwaj Krittika Bhattacharyya Ali Bijani Zebenay Workneh Bitew Somayeh Bohlouli Obasanjo Afolabi Bolarinwa Archith Boloor Ivana Božičević Zahid A Butt Rosario Cárdenas Félix Carvalho Jaykaran Charan Vijay Kumar Chattu Mohiuddin Ahsanul Kabir Chowdhury Dinh‐Toi Chu Richard G. Cowden Saad M A Dahlawi Giovanni Damiani Eugene Kofuor Maafo Darteh Aso Mohammad Darwesh José das Neves Nicole Davis Weaver Diego De Leo Jan‐Walter De Neve Kebede Deribe Keshab Deuba Samath D Dharmaratne Mostafa Dianatinasab Daniel Díaz Alireza Didarloo Shirin Djalalinia Fariba Dorostkar Eleonora Dubljanin Bereket Duko Maha El Tantawi Shaimaa I El-Jaafary Babak Eshrati Sharareh Eskandarieh Oghenowede Eyawo Ifeanyi Jude Ezeonwumelu Sayeh Ezzikouri Farshad Farzadfar Nazir Fattahi Nelsensius Klau Fauk Eduarda Fernandes Irina Filip Florian Fischer Nataliya A Foigt Masoud Foroutan Takeshi Fukumoto Mohamed M. Gad

Human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS) is still among the leading causes of disease burden mortality in sub-Saharan Africa (SSA), world not on track to meet targets set for ending epidemic by Joint United Nations Programme HIV/AIDS (UNAIDS) Sustainable Development Goals (SDGs). Precise HIV information critical effective geographic epidemiological targeting prevention treatment interventions. Age- sex-specific prevalence estimates are widely available...

10.1186/s12916-022-02639-z article EN cc-by BMC Medicine 2022-12-19

Background Estimating and analyzing trends patterns of health loss are essential to promote efficient resource allocation improve Peru’s healthcare system performance. Methods Using estimates from the Global Burden Disease (GBD), Injuries, Risk Factors Study (2019), we assessed mortality disability in Peru 1990 2019. We report demographic epidemiologic terms population, life expectancy at birth (LE), mortality, incidence, prevalence, years lost (YLLs), lived with (YLDs), disability-adjusted...

10.3389/fpubh.2023.1189861 article EN cc-by Frontiers in Public Health 2023-06-22

Abstract Cellular senescence occurs in response to endogenous or exogenous stresses and is characterized by stable cell cycle arrest, alterations nuclear morphology secretion of proinflammatory factors, referred as the senescence-associated secretory phenotype (SASP). An increase senescent cells associated with development several types cancer aging-related diseases. Therefore, senolytic agents that selectively remove may offer opportunities for developing new therapeutic strategies against...

10.1093/jb/mvae015 article EN cc-by-nc The Journal of Biochemistry 2024-02-15
Coming Soon ...